U.S. Transportation Stock News

Archrock (AROC) has been in focus after appointing Mohit Singh as Chief Financial Officer and Senior Vice President, a leadership change that arrives just days before the stock exits the Russell 2000 Dynamic Index. See our latest analysis for Archrock. Archrock’s share price has recently pulled back, with a 1 day share price return of down 5.08% and a 7 day return of down 12.30%. However, the 30 day and year to date share price returns of 7.57% and 38.15% keep the broader trend positive and...

In late June 2026, RTX’s Raytheon business secured a US$1.10 billion contract from the U.S. Navy to produce AIM-9X Block II missiles, alongside a reaffirmed quarterly dividend of US$0.73 per share and a subsequent removal of RTX from the Russell 1000 Dynamic Index. The sizeable AIM-9X award, coupled with plans to lift missile output to 2,500 units annually, underscores how defense demand and production scaling are increasingly central to RTX’s mix of risks and opportunities. We’ll now...

In late June 2026, Assured Guaranty Ltd. was removed from the Russell 1000 Dynamic Index, a benchmark followed by various index-linked investors. This index removal matters because it can force mechanical portfolio adjustments by index funds, altering trading volumes and the investor mix around the stock. We’ll now examine how Assured Guaranty’s removal from the Russell 1000 Dynamic Index may influence its previously outlined investment narrative. The latest GPUs need a type of rare earth...

Index removal puts Teekay Tankers in focus Teekay Tankers (NYSE:TNK) was recently removed from the Russell 2000 Dynamic Index, a shift that can influence trading flows as index funds and other passive investors adjust their holdings. This kind of index change often prompts active investors to reassess a stock, not only in terms of potential shifts in demand but also in relation to the company’s underlying business and valuation metrics. See our latest analysis for Teekay Tankers. Against the...

Seadrill (SDRL) has been removed from several Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth. This type of change can prompt index-tracking funds to adjust their positions. See our latest analysis for Seadrill. The Seadrill share price has shown mixed momentum, with a 2.63% 1 day share price return and a 2.13% 7 day share price return, set against a 30 day share price return that is down 10.16% and a 90 day share price return that is down 15.53%. The year to...

Nuvation Bio (NUVB) is back in focus after the U.K. Medicines and Healthcare products Regulatory Agency validated partner Eisai’s Marketing Authorisation Application for taletrectinib in advanced ROS1-positive non small cell lung cancer. See our latest analysis for Nuvation Bio. The latest U.K. MHRA validation comes as Nuvation Bio’s share price has climbed 18.26% over the past month and 28.09% over 90 days, while the year to date share price return is down 33.57% and the 1 year total...

Oracle stock has dropped sharply in recent weeks, yet over the past five years it is still up 71%. The key tension for investors is whether the recent pullback has left the shares looking cheap relative to their fundamentals or if the slide is simply catching up with earlier optimism about its AI and cloud push. Oracle has delivered a 71% gain over five years, which keeps the long term story intact even after the recent sell off. The push into AI infrastructure and large data center projects...

In late June 2026, CRISPR Therapeutics AG was added to several Russell growth indexes, including the Russell 2000, 2500, 3000, 3000E, and Small Cap Comp Growth benchmarks, expanding its presence across key US equity gauges. This broad index inclusion makes CRISPR Therapeutics more visible to growth-focused, benchmark-tracking investors, potentially reshaping how the stock fits into diversified biotech allocations. With this expanded Russell index presence, we’ll examine how heightened...

NVIDIA (NVDA) has just reshaped its leadership and partnerships, bringing in longtime Microsoft executive Nicholas Parker to run worldwide field operations while tightening ties with Palantir, LG Group, Verkada and other AI focused partners. See our latest analysis for NVIDIA. NVIDIA’s latest partnerships and leadership changes come as the stock has eased off recent highs, with a 30 day share price return of 5.01% and a 1 day decline of 1.39%. Longer term performance remains strong,...

Rapport Therapeutics (RAPP) has come into focus after being added to several Russell growth indices, a shift that can draw fresh attention from index tracking funds and benchmark oriented investors. See our latest analysis for Rapport Therapeutics. At a share price of $38.97, Rapport Therapeutics has seen short term share price returns ease slightly over the past week, while its 30 day and year to date share price returns remain positive. The 1 year total shareholder return of 223.67% points...

Global Ship Lease (GSL) has expanded its newbuilding program with five additional mid-size, ultra-high-reefer, wide-beam containerships, a US$413 million commitment that extends contracted revenue visibility well into the next decade. See our latest analysis for Global Ship Lease. At a share price of US$38.11, Global Ship Lease has seen its share price return advance 9.1% year to date, while the 1 year total shareholder return of 52.6% and 3 year total shareholder return above 2x highlight...

Recently, Missouri American Water, a subsidiary of American Water Works, requested approval from the Missouri Public Service Commission for new water and wastewater rates to fund about US$1.60 billion of infrastructure upgrades planned between June 2025 and May 2028, potentially affecting average residential bills from June 2027. This sizable rate case highlights how American Water Works seeks to recover extensive investment in system modernization, water quality improvements, and service...

Axsome Therapeutics, Inc. recently reported dosing the first patient in its FOCUS-3 Phase 3 trial of solriamfetol for adolescents with ADHD, while also being added to multiple Russell large-cap and growth indices and removed from several small-cap indices. This combination of a pivotal late-stage CNS trial in a new age group and a shift into larger-cap equity benchmarks may influence how investors think about Axsome’s clinical profile and market positioning. We’ll now examine how the Phase 3...

Mirum Pharmaceuticals recently reported past positive pivotal phase II results from the PROGRESS study of zilurgisertib in fibrodysplasia ossificans progressiva and secured US FDA priority review acceptance for its new drug application, with a decision scheduled for late September 2026. This combination of encouraging data in an ultra-rare indication and accelerated regulatory review could meaningfully broaden Mirum’s rare disease portfolio beyond its existing commercial assets. We’ll now...

Regencell Bioscience Holdings (RGC) is back in focus after disclosing cooperation with a U.S. Department of Justice investigation into trading in its shares, alongside mounting legal costs and going concern warnings. See our latest analysis for Regencell Bioscience Holdings. At a share price of $6.37, Regencell Bioscience Holdings has seen sharp selling pressure recently, with the 30 day share price return down 68.13% and the year to date share price return down 68.99%. The three year total...

In late June 2026, Vor Biopharma Inc. was added to a wide range of Russell indexes, including the Russell 2000, 2500, 3000, Microcap, and multiple related Growth and Value benchmarks. This broad inclusion significantly expands Vor Biopharma’s presence in benchmarked portfolios, potentially increasing its visibility among index-tracking and institutional investors. We’ll now examine how Vor Biopharma’s broad Russell index inclusion shapes the company’s investment narrative in light of recent...

American Tower (AMT) has just been added to several Russell value and defensive indices, drawing fresh attention to the stock as it posts a 1.53% session gain ahead of its July 28 earnings report. See our latest analysis for American Tower. Looking beyond the latest session, American Tower’s share price is down 14.47% over the past 30 days and 5.02% year to date, while the 1 year total shareholder return has declined 22.24%. This suggests momentum has been fading even as the new index...

In late June and early July 2026, CACI International announced that Dr. Dave Young became Executive Vice President and Chief Operating Officer and that returning leader Tom Kirkland was appointed Executive Vice President of Electronic Warfare, both joining the company’s executive leadership team. These appointments bring deep space, defense electronics, and battlefield technology experience into CACI’s top ranks, reinforcing its push toward mission-focused, technology-first national security...

In late June and early July 2026, Redwire Corporation’s subsidiary amended its credit agreement to lift revolving credit capacity from US$30.00 million to US$50.00 million while prepaying US$40.00 million of term loans, and separately secured a contract via Taiwan Color Optics Inc. to supply Penguin Mk2.5 VTOL uncrewed aerial systems to the Taiwan Coast Guard. Taken together, the new Taiwan Coast Guard UAS contract and the reshaped credit facilities highlight both operational demand for...

In the past quarter, MSC Industrial Direct Co., Inc. reported fiscal third-quarter 2026 sales of US$1,047.08 million and net income of US$80.36 million, with diluted EPS from continuing operations rising to US$1.44 from US$1.02 a year earlier, alongside margin expansion and productivity gains. Beyond the headline beat, the company’s sales force optimization, Mission Critical efficiency program, and raised free cash flow outlook underscored how operational improvements are feeding directly...

In recent days, CenterPoint Energy, Inc. in Houston reported that analysts now expect its Q2 2026 diluted EPS to be US$0.38, implying year-over-year growth of 31% ahead of the upcoming earnings release. Analysts also project CenterPoint Energy’s EPS for fiscal 2026 at US$1.91, suggesting that expectations for earnings expansion are becoming a central focus for investors ahead of the report. With analysts forecasting a 31% jump in quarterly EPS, we’ll now examine how this shapes CenterPoint...

Northwest Bancshares recently reported past first-quarter 2026 results that topped market expectations, with adjusted EPS of US$0.35 on revenue of US$175.06 million, and appointed Chad Ballard as Chief Information Officer effective May 18. This combination of earnings outperformance and a new technology leader highlights how operational execution and digital capabilities are becoming increasingly important for the bank’s business profile. Next, we’ll examine how the stronger-than-expected...

Amgen (AMGN) is back in focus after a federal judge blocked Colorado’s proposed 70% price cap on Enbrel, which removed an immediate regulatory threat to one of the company’s key revenue drivers. See our latest analysis for Amgen. The court decision has come on top of an already strong run in Amgen’s stock, with a 1-day share price return of 3.55% and a year to date share price return of 14.20%, while total shareholder return sits at 29.22% over one year and 87.63% over three years. This...

WesBanco (WSBC) has been removed from several Russell growth and small cap indexes, a change that can prompt mechanical buying and selling by index tracked funds and may influence short term trading volumes. See our latest analysis for WesBanco. Despite the recent index removals, WesBanco’s share price has been firm, with a 30 day share price return of 15.27% and an 18.90% share price return year to date. Over a longer horizon, the bank’s total shareholder return of 23.01% over one year and...